|
PHKA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.69270000028155E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.92850000027656E-07 |
| Normal-vs-Stage2 |
6.770100E-04 |
| Normal-vs-Stage3 |
2.598400E-02 |
| Normal-vs-Stage4 |
1.329830E-02 |
| Stage1-vs-Stage2 |
5.076600E-01 |
| Stage1-vs-Stage3 |
7.123700E-02 |
| Stage1-vs-Stage4 |
3.543200E-01 |
| Stage2-vs-Stage3 |
8.985700E-02 |
| Stage2-vs-Stage4 |
2.167600E-01 |
| Stage3-vs-Stage4 |
6.674400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11929999999394E-06 |
| Normal-vs-AfricanAmerican |
3.982200E-02 |
| Normal-vs-Asian |
1.955270E-03 |
| Caucasian-vs-AfricanAmerican |
7.758400E-01 |
| Caucasian-vs-Asian |
6.579600E-01 |
| AfricanAmerican-vs-Asian |
5.636800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.201470E-04 |
| Normal-vs-Female |
1.38350000000731E-06 |
| Male-vs-Female |
9.277200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.23360000051187E-07 |
| Normal-vs-Age(41-60Yrs) |
7.999100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.057670E-03 |
| Normal-vs-Age(81-100Yrs) |
9.852600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.522240E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.901000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.039000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.705800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.466800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.404000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.438600E-04 |
| Classical-VS-Follicular |
2.135400E-01 |
| Classical-VS-Other |
7.283600E-02 |
| Classical-VS-Normal |
1.20130000391683E-08 |
| Tall-VS-Follicular |
9.386100E-02 |
| Tall-VS-Other |
5.657000E-01 |
| Tall-VS-Normal |
5.005600E-01 |
| Follicular-VS-Other |
3.120800E-01 |
| Follicular-VS-Normal |
1.126260E-02 |
| Other-VS-Normal |
7.708800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55569999999284E-05 |
| Normal-vs-N1 |
4.524700E-03 |
| N0-vs-N1 |
9.355200E-01 |
|
|
